Burrell Terry-Ann

Burrell Terry-Ann holds the position of Chief Financial Officer at Beam Therapeutics Inc., where she is responsible for managing the company's financial health and strategic direction. Her recent insider trading activity includes a series of sales reported between February 2, 2024, and April 29, 2024, with total amounts ranging from $771.8K to $1.3M. Notably, her largest disclosed move involved a grant or exercise valued at approximately $1.34 million on February 2, 2024, reflecting her active role in the company's financial operations.